Spexin treatment has shown to inhibit inflammation by reducing blood IL-6 level in a metabolic syndrome rat model induced by high-fructose diet and blocking macrophage recruitment to adipose tissue in an obese mouse model [37, 38]. The gene discussed is IL6; the disease is metabolic syndrome.